Finding the best prices at pharmacies near you...

Prescription & Medication Blog

At RxSpark we believe prescription drugs and medication should be accessible and affordable for all Americans. In addition to the savings, discounts, and convenience that RxSpark provides, the RxSpark Blog is here to bring you information, news, current events, and important upates on topics that affect healthcare and prescription drugs. Be sure to check back frequently for updates, and if you find any information that is particularly helpful please don't hesitate to share!



5 Tips to Help you Avoid Cold and Flu this Winter

It's that time of the year when the temperature starts to drop, winter weather is setting in, and more and more people are coming down with a cold or flu. It is important to stay healthy during the colder months of the year, but this is not always easy, particularly as you are increasingly exposed...

Read More

Depression 'higher among patients with atopic dermatitis'

Depression and anxiety is more commonly diagnosed in patients suffering atopic dermatitis than among the rest of the US population, a recent survey by the National Eczema Association (NEA) suggests. October is Eczema Awareness Month, during which the NEA is highlighting the impact of eczema on...

Read More

Psoriasis drug Stelara now indicated for adolescent patients

The US Food and Drug Administration (FDA) has approved the indication of Stelara (ustekinumab) for adolescent patients with moderate to severe plaque psoriasis. Janssen Biotech, the manufacturer of the drug, described the approval as a "significant milestone" in the treatment of young people with...

Read More

5 Medical Conditions Where Antibiotics May Be Unnecessary

Antibiotics such as Cipro (ciprofloxacin) and Amoxil (amoxicillin) are prescribed to treat a staggering range of different medical conditions, but their pervasive use could be reducing their efficacy in the long-term. The more these drugs are used, the greater the risk of antibiotic-resistant...

Read More

FDA announces improvements to Adverse Event Reporting System

The US Food and Drug Administration (FDA) has announced improvements to its Adverse Event Reporting System (FAERS). The system is a database of reported medication issues, including product quality complaints leading to adverse events, medication error reports and other adverse event...

Read More

FDA grants for clinical trials 'may lead to lower drug prices'

Over the next four years, more than $22 million in grants have been awarded for clinical trials and research into treatment for patients with rare diseases, the US Food and Drug Administration (FDA) has announced. In a statement released by the regulatory body, FDA Commissioner Scott Gottlieb, MD,...

Read More

FDA approves new pediatric indication for Tracleer

The US Food and Drug Administration has approved a new indication for the Actelion Pharmaceutical's drug Tracleer (bosentan). The medication may now be used to treat pediatric patients aged three and over who suffer from idiopathic or congenital pulmonary arterial hypertension...

Read More

HIV drug Truvada 'safe for young males'

A combination therapy used to reduce the chances of HIV infection in adult patients is safe for adolescents, a new study by the National Institutes of Health network suggests. Truvada (tenofovir, emtricitabine) is a single pill combination drug currently approved as a pre-exposure prophylaxis...

Read More

cUTI drug Vabomere 'available in US by the end of 2017'

Vabomere (meropenem and vaborbactam), an injection for treating adult patients with complicated urinary tract infections (cUTIs) will be available in the United States. by the end of 2017. Rempex Pharmaceuticals was granted approval for the antibiotic by the US Food and Drug Administration (FDA),...

Read More